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Objective: To develop guidance for clinicians about essential elements that can sup-
port clinical decision-making in the diagnostic workup of young onset dementia.
Methods/design: Three iterations of a modified e-Delphi consensus survey compris-
ing 23 international expert clinicians specialising in diagnosis of young onset
dementia.
Outcome measures: A priori consensus was pre-defined as 80% of experts ranking
statements in the upper threshold on a seven-point Likert scale that ranged from
“not important at all” to “absolutely essential” to diagnosis.
Results: 80% consensus was reached on 48 statements that were rated as “abso-
lutely essential” or “very important” to a comprehensive assessment of dementia in a
younger adult. In order to inform a subsequent audit of clinical records in which com-
pliance with these statements was assessed, the statements were divided into a Min-
imum Standard, (consisting of the 15 statements voted by all experts as being
“absolutely essential” or “very important”) and a Gold Standard where 48 statements
were voted by 80% of the experts as being “absolutely essential” or “very important”.
The experts’ response rate across the three rounds was 91.3%.
Conclusion: A Minimum Standard and Gold Standard have been created for the diag-
nostic workup of young onset dementia. The standards provide a clinically useful tool
for decision-making, particularly for generalists and those with less experience in the
field. The standards will be used to inform a UK case note audit of recently diagnosed
patients with young onset dementia.
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1 | INTRODUCTION
1.1 | Young onset dementia and diagnosis
Young onset dementia (YOD) refers to dementia diagnosed in those
aged 65 years and under. The differential diagnosis of YOD encom-
passes complex presentations of the common primary neurodegener-
ative diseases as well as autoimmune, inflammatory, late onset
metabolic and hereditary/familial causes.1 While Alzheimer's disease
(AD) makes up the majority of cases in younger adults, it represents a
significantly smaller percentage than in late onset disease (LOAD)2,3
and presentations are generally non-amnestic in nature.4 Because of
the complexity of presentation and often atypical nature of presenting
symptoms, YOD is poorly recognised and often misdiagnosed5,6 and
advice to support clinicians with identification and assessment of key
symptoms in the diagnostic workup is lacking. In particular, clinicians
with less familiarity of dementia in younger adults can be unaware of
red flag symptoms and essential investigations that can help identify
the complex subtypes of dementia which are more common in youn-
ger people. Furthermore, routine assessments tailored to older
patients are often insufficient to identify the significant overlap
between psychiatric disorders and neurodegenerative disease in this
age group and this can lead to delay in specialist referral, clinical
under-investigation, misdiagnosis, and delays in obtaining a definitive
diagnosis reference (7–9).
Given these concerns, a UK-based study, called The Angela Pro-
ject, aimed to develop guidance on best practice in diagnosis. An in-
depth scoping review of the literature highlighted 29 papers identify-
ing red flags in the clinical approach to diagnostic assessment of YOD
and concluded that a clinically rigorous and systematic approach is
necessary inorder to avoid misdiagnosis or under diagnosis for youn-
ger people with dementia.7 To further a systematic approach to diag-
nosis in YOD, the present paper reports the findings from an
international Delphi study with secondary care clinical experts, that
identified key elements that support clinical decision-making. The Del-
phi method was adopted as it is an appropriate method for exploring
clinical decision-making by consensus.
Our objectives were to explore the (a) key indicators essential for
high quality assessment and diagnosis of YOD, and to (b) identify rep-
resentative opinion from clinicians in a range of disciplines typically
involved in diagnosis of YOD.
2 | METHOD
2.1 | Delphi method
The Delphi process10,11 is an expert consensus method that can be
used to develop best practice guidelines using practice-based evi-
dence. This process comprises a series of structured surveys and is
used to collate opinions on a set of matters in order to gain a consen-
sus of opinions.11 In diseases where clinical evidence is lacking it is a
method deemed suitable for the development of guidelines on
diagnosis and management and is often used in healthcare decision-
making.12 The goal is to translate professional experience into
informed judgement and to support effective decision-making with an
emphasis on stability of group opinions rather than individual opin-
ions. The Delphi approach allows anonymised individuals to freely
express their opinions, reconsider them in the light of collective opin-
ions from the whole group and, with each round, gain consensus.13
The Delphi process used here to determine consensus about key
elements in the assessment and diagnosis of YOD involved four steps:
(a) formation of the expert panels, (b) survey development informed
by a literature search, (c) data collection and analysis, and (d) guide-
lines development. This paper will focus primarily on the first three
steps, although please see O'Malley et al, (2019) for the in-depth liter-
ature review that was conducted to inform this study.7
Ethics: The Angela Project was approved by the Health Research
Authority in England and by the South Central Berkshire Research
Ethics Committee (REC ref.: 17/SC/0296).
2.2 | Panel member selection and participants
Purposive sampling was used to select 52 experts who had a specific
interest (such as through research or through their own practice) in
YOD and these experts were approached to take part in a Delphi con-
sensus study on diagnosis of YOD (UK - N = 28, Female = 4, Male = 24;
International - N = 24, Female = 7, Male = 17). Criteria for experts
were that they were (a) affiliated with a YOD service (b) were authors
from papers found through the scoping literature review previously
conducted (see O'Malley et al, 2019 review), or (c) were identified via
snowball sampling techniques. We aimed to approach a similar num-
ber of UK national experts and international experts to represent
diversity of practice. In response to the invitation, 23 experts agreed
to participate in the Delphi study (UK (N = 15) Female = 1, Male = 14;
International (N = 8), Female = 5, Male = 3). Please see Table 1 for the
demographics of the Delphi experts.
Key points
• Delay to diagnosis, misdiagnosis as a psychiatric condi-
tion and under-investigation of young onset dementia is
common because of a lack of expertise.
• Routine assessments tailored to older patients are insuffi-
cient to identify the complex presentations usually seen
in young people with dementia
• A Minimum and Gold Standard set of indicators for high
quality assessment of young onset dementia have been
derived using a Delphi consensus study with international
experts.
• The standards provide a tool to aid clinical decision-mak-
ing for those with less experience in the field.
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Experts were approached by means of email and were sent a
“Delphi invitation”. Consent was considered implicit by completing
the first round of the Delphi.
2.3 | Survey and rounds
The Delphi questionnaires were made available using the Bristol Online
Survey (BOS) which allowed easy access for all the experts. A preliminary
pilot study was conducted with a team of independent experts from a
leading dementia research institution to provide initial feedback on the
clinical vignette which featured in the first round on the survey.
The study was conducted in three phases spread over the period
from October 2017 to May 2018.
Delphi Round 1: Consensus development began with four open-
ended questions for experts based upon a clinical case vignette of an
individual displaying possible symptoms of YOD. The vignette was
developed by collating self-reports of prodromal symptoms of demen-
tia through our public and patient involvement (PPI) forum of people
affected by YOD, as well as by asking independent clinical experts in
YOD. The vignette was written in such a manner as to provoke
diverse and multiple opinions and/or multiple alternative pathways to
further assessment (see Appendix A for the vignette and questions).
Experts were encouraged to provide comments and insights into how
they interpreted the clinical history and symptoms, weighed them in
the balance, and made decisions about how they might proceed to
further assessment. Following data collection, three of the authors
met on two occasions for Round 1 workshops to read, group similar
items, collapse and define the key themes that emerged from the
open-ended responses.
Analysis of the key themes included selecting the most represen-
tative statement reported by the experts, using exact wording with
only minor edits if necessary.
Delphi Round 2: Experts were asked to rate the statements gener-
ated in Round 1 via the Bristol Online Survey (www.onlinesurveys.ac.
uk) on a Likert scale of 1-7, ranging from “not important at all”, to
“absolutely essential” (see Table 2).
Delphi Round 3: The statements that had overall mean scores
below 6 (indicating they were moderately important or not important)
and/or did not reach consensus in Round 2 were re-presented to the
experts in Round 3. Experts were asked to re-read and reconsider
their scoring if they wished. To provide additional decision-making
support to the experts, given the variety of clinical specialisms, we
provided the mean and standard deviation (SD) of the whole expert
group per statement, as well the mean and SD per specialism (e.g.
neurologists) dependent on the discipline of the statement/where
appropriate.
3 | DATA ANALYSIS
3.1 | Round 1
Round 1 identified 138 individual items about the case vignette which
were grouped across 11 key areas of assessment and investigation
from the qualitative reports. (See Table 3 for an example of grouped
free text quotes about mood). The items were further collapsed and
grouped into universal descriptions to create a final list of 72 state-
ments for rating.
3.2 | Round 2
Of the list of 72 unique statements presented in the second round
(see Appendix B), 43 of the statements reached 80% consensus after
Round 2, meaning they were rated in the upper threshold with scores
TABLE 1 Delphi panel members' specialisms
Specialism UK International Total Experience of experts
Neurology 10 2 12 All currently clinically active
UK- in specialist cognitive neurology/YOD hospital-based
clinics
International -university hospital memory services/specialist
memory service
Psychiatry 4 3 7 All currently clinically active
UK - in YOD services/clinics in community or hospital
International – specialist memory clinics and active
researchers
Neuropsychology 0 3 3 2 currently clinically active -Specialist YOD care services/
communities/hospital
1 active researcher
Gerontology 1 0 1 Clinically active clinician outpatient setting, leading researcher
in field
Total 15 8 23
Note: International experts included those from The Netherlands, Germany, Australia, Hungary, Ireland and France.
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of “absolutely essential” and “very important”. Of these 43 statements,
15 statements were rated by all experts as being absolutely essential or
very important, and a further 28 statements were rated by 80% of the
experts as being “absolutely essential” or “very important”. Please see
Table 4 for the final list of statements that met consensus and Appendix
C for statements that did not reach consensus after all rounds.
3.3 | Round 3
In total there were 29 statements where 80% consensus was not
reached, or the statements were ranked as moderately important or
less after Round 2. These were sent back to the experts for reconsid-
eration in Round 3. In this round, experts were provided with the per-
sonal rating given for the statement in the previous round (Round 2),
(a) the collective group rating of the statement and the SD (SD), (b)
where applicable, the Specialist Mean Scores and Specialist SD from
experts from the specific area of specialism that the statement
reflects. Twenty-one of the 23 experts responded in Round 3
(response rate 91.30%), with 16 experts reconsidering and changing
their scores based on overall mean scores and the mean scores of
each discipline. Five experts were happy with their original Round 2
scores and did not change their scores. Round 3 resulted in the addi-
tion of five more statements reaching consensus in the upper thresh-
old (see Table 5).
As a result, the final list of statements following the three itera-
tive rounds consisted of 48 statements where 80% consensus was
reached that they were “absolutely essential” or “very important” to
diagnosis in a younger adult. (see Table 4).
At the outset of the study, consensus was agreed as achieved on
an item if at least 80% of the respondents were in agreement and the
composite score fell in the upper threshold, defined as scores in the
“absolutely essential” or “very important” range on the 7-point Likert
scale.
Earlier studies have also used the certain level of 80% agreement
to identify very high levels of consensus.14
4 | RESULTS
The quality indicators identified by experts via consensus in Table 4,
and particularly in free text written feedback, emphasised a general
approach to the assessment, which is compassionate, collaborative
and inclusive. As a philosophy of care, all experts agreed that
supporting individuals and families throughout the course of their ill-
ness, offering flexible management with appropriate professionals
over time and with disease progression was vital up to end of life care.
However, individual autonomy was respected and recognition that a
“ight touch” may be preferable to many younger people with demen-
tia, especially early in their illness when the condition is stable, and
support could be considered intrusive. Ensuring participants in the
process were clear about potential outcomes, including the likelihood
of receiving a diagnosis, before proceeding by employing pre-assess-
ment counselling, was also considered important by 100% of experts.
In free text, the need to differentiate from psychiatric diagnoses
was emphasised together with need to keep an open mind about the
myriad of less common causes of dementia that can occur - including
genetic causes, prion diseases, less common forms of degenerative
disease, and the role of metabolic, endocrine and neoplastic disease.
The difficulty in differentiating dementia in patients with long-stand-
ing illnesses like schizophrenia and resistant depressive / affective dis-
orders, and individuals with prior learning difficulties where
knowledge of premorbid functioning is essential, was acknowledged.
Equally, that very young patients (under age 40) open a up a much
wider diagnostic differential of genetic, neurometabolic and other
unusual disease processes. Experts acknowledged that while a timely
and accurate diagnosis was important, as patients had often experi-
enced delays and multiple steps before reaching an expert, there were
equally risks in making a premature diagnosis because of the profound
impact having a diagnosis would have on the future, and the chal-
lenges and risk associated with this.
Obtaining a collateral history was considered to be an essential
component of history taking mentioned by 100% of experts, in partic-
ular, noting any discrepancy between patient self-report and that of a
TABLE 2 The 7-point Likert scale used in the Delphi study
Not at all important Low importance Slightly important Neutral Moderately important Very important Absolutely essential
TABLE 3 Free text quotes from round 1 that related to mood
Statements
Round 1 raw text quotes relating
to mood
To ask about sleep I would be concerned over the possibility
and need to rule over further a
depressive component to his
presentation with dishevelled
appearance, anhedonia and poor sleep
(1023).
Exclude symptoms of
mood disorder
poor sleep: can affect memory, could be
mood related (1010).
Use a mood inventory
such as GDS, BDI,
HADS
Questionnaires to assess mood (1016).
Mood screening (1011).
Formal mood inventory (1003).
story has elements to suggest an affective
disorder, but this should not be taken
at face value, especially without prior
psychiatric history, and the degree of
self-neglect. The ACE3 pattern is not
suggestive of problems secondary to an
affective disorder, for example, the low
visuospatial scores, and language
deficits (1013).
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TABLE 4 Minimum and Gold Standard statements
Group Statements rated by experts Mean SD
total sum of
respondents
rating 6 or 7
Pre-assessment and
communication
Multiple professionals are required over time to allow
flexible assessment with support to end of life
6.17 1.07 21
Pre-assessment and
communication
Diagnosis of YOD is a clinical judgement and has a
profound impact on the future, so it important to
convey this to patient and their family and remain
open to the need to review and potentially modify
opinion
6.70 0.47 23
Pre-assessment and
communication
Establishing rapport to enable open reporting of
symptoms
6.74 0.45 23
Pre-assessment and
communication
The assessment should start with counselling to
ascertain What patient and supporters require
6.00 0.90 19
Pre-assessment and
communication
Ensuring the patient has capacity 6.09 0.90 19
History taking: importance of the
following information when
taking a history
To ask an informant (eg, wife/husband) for a collateral
history
6.91 0.29 23
History taking: importance of the
following information when
taking a history
To understand the symptom type and the mode of
onset
6.83 0.39 23
History taking: importance of the
following information when
taking a history
More information about loss of sympathy/empathy
towards others, disinhibited behaviour, change in
food preferences and changes in personality
6.74 0.45 23
History taking: importance of the
following information when
taking a history
To enquire about changes in physical health 6.52 0.51 23
History taking: importance of the
following information when
taking a history
If there have been any changes in activities of daily
living
6.87 0.34 23
History taking: importance of the
following information when
taking a history
To ask about changes in behaviour 6.91 0.29 23
History taking: importance of the
following information when
taking a history
To consider previous medical conditions 6.52 0.67 21
History taking: importance of the
following information when
taking a history
To take a drug history 6.70 0.63 21
History taking: importance of the
following information when
taking a history
To ask about sleep 6.39 0.72 20
History taking: importance of the
following information when
taking a history
To take an alcohol history 6.74 0.54 22
Family history To ask if a first degree relative has had young onset
dementia
6.83 0.39 23
Family history To obtain a three-generation history of young onset
dementia from the patient
6.17 0.89 20
Medical history To have a full medical history (including cardiovascular
history)
6.70 0.47 23
Physical examination A Physical Examination 6.17 1.11 20
Risk assessment To evaluate risks, for example driving or in the work
place
6.61 1.08 22
Psychiatric assessment A thorough psychiatric history should be conducted. 6.52 0.67 21
(Continues)
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TABLE 4 (Continued)
Group Statements rated by experts Mean SD
total sum of
respondents
rating 6 or 7
Past psychiatric history Ask about past psychiatric symptoms 6.52 0.67 21
Psychiatric assessment Include mental state examination 6.22 1.02 19
Psychiatric assessment Exclude Symptoms of mood disorder 6.70 0.56 22
Psychiatric assessment Exclude psychotic symptoms 6.39 0.58 22
Psychiatric assessment Establish if there is a known history of learning
disability
5.91 1.41 19
Neurological assessment A thorough neurological assessment should be
conducted
6.83 0.39 23
Neurological examination: key
components should include
Eye movements 6.52 0.67 21
Neurological examination: key
components should
Cerebellar signs 6.48 0.67 21
Neurological examination: key
components should include
Tongue or limb fasciculation 6.43 0.73 20
Neurological examination: Frontal signs 6.17 1.19 20
Neurological examination: Extrapyramidal features 6.52 0.73 22
Neurological examination:
examine for
Motor skills 6.57 0.59 22
Neurological examination examine
for
Praxis 6.65 0.49 23
Neurological examination examine
for
Parkinsonism 6.65 0.49 23
Neuroimaging A thorough neuroimaging investigation should be
included
6.87 0.34 23
Neuroimaging investigation should
include
Baseline structural neuroimaging 6.74 0.54 22
Neuroimaging MRI should be the initial imaging investigation 6.48 0.95 20
Neuroimaging MRI head to agreed dementia protocol 6.22 0.83 19
Dementia protocol should include T1 6.30 1.15 19
Dementia protocol should include T2 6.13 1.01 19
Neuroimaging FLAIR 6.17 0.98 20
Neuroimaging include Assessment of MTL atrophy on MRI 5.87 1.29 18
Neuropsychological assessment An ACE -III is useful to understand the cognitive profile 5.83 0.64 18
Neuropsychological assessment Patterns of cognitive deficits provide clues to disease
aetiology on the ACE-III
5.91 0.72 18
Neuropsychological assessment Detailed neuropsychology testing should be
considered if there is under-performance on
screening measures
6.13 0.95 18
Neuropsychological assessment The profile of results is important on the ACE-III, that
is, the pattern of what looks impaired and what is
less affected, rather than the score itself
6.26 0.92 20
Support to end of life Support is required from diagnosis to end of life care 6.70 0.47 23
Note: The following table includes the 48 statements that have been highlighted by 80% of the experts as being “absolutely essential” or “very important”
to making a comprehensive assessment of dementia in a younger adult. The right column indicates the number of experts that rated each statement as
‘absolutely essential’ or ‘very important’ and the statements have been grouped according to aspects of the clinical assessment. Statements highlighted in
green, indicate statements that were rated by all experts (ie, 100% consensus) as being absolutely essential or very important and is our Minimum Standard
for diagnosis. Mean results scores of 6 reflect statements being “very important”, while the top score of 7 reflects the statement being “absolutely essen-
tial”. ACE-III refers to the Addenbrooke's Cognitive Examination-III.
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knowledgeable informant. Enquiry regarding precise type of symptom
onset, chronology and progression, and the current symptom profile,
should be ascertained in addition to determining which key areas have
not changed; for example, physical health/ neurological status. Further
information about social and family factors was considered essential -
these factors included any stresses and current level of family
resource/support/children and their concerns and views, relevant
financial and legal matters, and any difficulties at work and how diffi-
culties were impacting on day-to-day activities. Weight was given to
changes in non-cognitive symptoms, particularly appearance, behav-
iour and personality, with salience particularly in direct enquiry about
international consensus criteria for behavioural variant
Frontotemporal dementia (FTD).
The experts emphasised ascertaining information to aid discrimi-
nation between a possible cognitive disorder and a functional or dual
diagnosis - such as symptoms of depression and the role of any
aetiological factor such as alcohol or illicit drug use. Caution advised
against taking a history of such conditions at face value as explanation
of current presentation, especially in the absence of any previous psy-
chiatric history.
Identifying “red flags” to differentiate from mood disorders and
other psychiatric conditions was reflected in consensus on taking a
thorough psychiatric history and mental state examination to enquire
about symptoms of mood/sleep and abnormal beliefs or perceptions.
Experts reached consensus about the value of self- or observer-rated
scales of mood or behaviour, but did not agree on which tool was
most appropriate. It may be that whilst experts recognised the impor-
tance of a mood inventory, they may not have had the “discipline spe-
cific” expertise to call judgement on which specific tool is most
suitable.
Consensus was reached on the value of obtaining further back-
ground information about biography and family history of dementia.
This included other neurological conditions if known (including
subtype and any genetic mutations) in first degree relatives, and by
taking a three-generation family history.
Taking a full medical history, particularly with regard to medica-
tion and cardiovascular risk factors, and performing a focused physical
and neurological examination reached 100% consensus. Dementia
blood screens, autoimmune disorder screens and other baseline inves-
tigations such as chest X-ray and ECG to exclude physical causes did
not. Many experts made it clear in free text that there is an expecta-
tion that such investigations would already have been performed by
GPs before referral, supporting the view that it is important to check
for reversible or rare physical causes in a young person.
Neurological examination was regarded as absolutely essential,
and the preferred approach advocated exclusion of abnormal eye
movements, cerebellar signs, extrapyramidal features, motor skills,
frontal release signs and tongue and limb fasciculation. Examination
for praxis and parkinsonism was considered to be the minimum stan-
dard required.
The clinical experts considered that the Addenbrookes Cognitive
Examination-III (ACE-III) was a useful tool and the cognitive profile
and pattern of deficits were more important than objective scores in
helping understand aetiology. Detailed neuropsychology should be
considered if there is underperformance on cognitive measures or in
cases of clinical uncertainty with normal imaging. Normal cognitive
scores in younger people in the presence of impaired activities of daily
living did not prompt experts to identify functional assessments with
an Occupational Therapist as a valuable complementary tool, reaching
only 70% consensus (16 of the 23 experts rated this as “absolutely
essential” or “very important”), although it was not considered
unimportant.
Only 17% of experts valued CT brain scans as important baseline
investigations, the remainder agreeing that MRI should be the first
investigation. A defined dementia protocol including as T1, T2, and T2
FLAIR images but not Diffusion Weighted Imaging (DWI) or
TABLE 5 Statements that made the final list for the Gold Standard following reconsideration during Round 3 of the Delphi
Group
Statements rated by
experts
Round
2 mean Round 2 SD
Number of
respondents Round 3 mean Round 3 SD
Number of
respondents
Psychiatric assessment Include mental state
examination
6.13 1.10 17 6.22 1.02 19
Neuroimaging MRI head to agreed
dementia protocol
5.91 1.35 17 6.22 0.83 19
Neuropsychological
assessment
An ACE-III is useful to
understand the
cognitive profile
5.70 0.76 16 5.83 0.64 18
Neuropsychological
assessment
Patterns of cognitive
deficits provide clues
to disease aetiology on
the ACE-III
5.83 0.89 16 5.91 0.72 18
Neuropsychological
assessment
Detailed
neuropsychology
testing should be
considered if there is
underperformance on
screening measures
5.91 0.95 16 6.13 0.95 18
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Susceptibility Weighted Imaging (SWI) reached 80% consensus in our
upper threshold (i.e. “absolutely essential”; or “very important” to
diagnosis).
Consensus about the value of access to quantitative volumetric
analysis of medial temporal atrophy as a valuable biomarker in this
age group was not reached, although assessment of medial temporal
lobe atrophy by visual analysis was not.
In the event of normal baseline imaging, the experts were asked to
rate which further investigations would be considered helpful. Cerebro-
spinal fluid (CSF) analysis for Tau and Amyloid biomarkers was rated by
15 experts as “absolutely essential” or “very important” with none rating
it as of low importance although it did not reach consensus. Compara-
tively, Amyloid PET was rated as “absolutely essential” or “very impor-
tant” by nine experts and four rated it as of “low importance” or “not at
all important”. There was general agreement that HMPAO SPECT was of
limited value especially if FDG-PET was available.
5 | DISCUSSION
Using data from a three-stage modified Delphi study, consensus was
reached on 48 essential components of a high-quality diagnostic
workup for YOD as determined by clinical experts. Our results are
consistent with previous literature reviews which identified the need
for a systematic approach to clinical history taking, examination and
investigation in YOD.7,15
In line with our results, other studies have stressed the need for
rigorous enquiry and physical examination to assess key features of
YOD including the potentially wide range of physical presentations of
secondary dementias or dementia “plus” syndromes16; the increased
likelihood of familial and genetically inherited conditions as a cause of
young onset dementia17; and the salience of direct enquiry about
international consensus criteria for behavioural variant
Frontotemporal dementia (FTD)18 where discrimination of FTD from
Alzheimer's disease using conventional cognitive testing maybe
unhelpful. In line with best practice in imaging,15,16 a defined MRI
dementia protocol including as T1, T2, and T2 FLAIR images was
supported as was use of visual inspection of medial temporal lobe
regional atrophy to discriminate Alzheimer's disease.
Consensus regarding the importance of mental state examination
and the value of self- or observer-rated scales of mood or behaviour
is designed to mitigate the high rates of psychiatric misdiagnosis of
YOD, particularly as depression, identified in the literature.19
Despite the potential advent of disease modifying treatments and
the value in identifying prodromal dementia and high-risk populations,
most likely to be those with YOD, no consensus was reached about
the role of molecular biomarkers for diagnosis.
5.1 | Strengths and limitations of the study
In order to ensure that opinions were not biased, the researchers
adopted a rigorous approach maintaining anonymity throughout to
allow frank discussion. Written feedback about decision-making was
encouraged to limit bias and avoid preconceptions. However the lack
of representation of allied health professionals, such as occupational
therapists and speech and language therapists, in the expert panel is
likely to have influenced outcomes, although medically trained profes-
sionals are more likely to be directly involved in the final diagnostic
decision. This is relevant to the Delphi results as working in a multi-
disciplinary environment with access to other key professionals was
considered an important criterion by the participants.
As with all Delphi studies, the views expressed represent those of
experts in specific disciplines and do not necessarily reflect the views
of all experts in that field. In our study, the range of experts who
agreed to participate may indicate bias in the selection process with
those who have strong views being more likely to participate. As the
sample was varied in terms of expertise in secondary care, care was
taken to ensure that statements of importance by certain professional
groups were not overlooked due to a lower number of experts from
their discipline by providing experts with the “discipline” average
score as well as the overall average when reviewing scores in Round
3. Thus, a statement not making the final list may have been due to
lack of representation from a professional group in the expert panel,
rather than it not being important to the diagnostic workup.
Whilst there is possibility of bias around particular concepts of
assessment, we selected experts from diverse institutions who are
highly qualified in the field, and conducted the survey in a rigorous
manner by maintaining the anonymity of all participants to limit
potential bias. The free text feedback was used to ensure that the
structure and content of the survey did not impose preconceptions
and experts were able to comment freely. Feeding back the scores of
specialists from other disciplines on the statements facilitated re-con-
sideration of opinions, and suggests that final values were true reflec-
tions of expert views.
Other Delphi studies provide evidence that panels of similarly
trained experts, especially where there is limited evidence and small
numbers of experts in a field, can be used to develop reliable criteria
to inform judgement and support clinical decision-making. The
response rate of 91.3% across the three rounds is considerably higher
than guidance suggests is necessary for a reliable Delphi study, where
a response rate of 70% or higher is necessary. Although there is rec-
ognition that the sample size for constructing a Delphi panel is not a
statistically-bound decision, reliable outcomes have been obtained
from Delphi panels consisting of a relatively small number of Delphi
experts. Recent analysis using bootstrapping methodology demon-
strated that the response characteristics of a small expert panel in a
well-defined knowledge area are stable in light of augmented
sampling.13
Although steps have been taken to conduct the study in a rigor-
ous manner, the template outlined is provided for guidance only and
not as a definitive tool. It is hoped that it may help improve standards
and provide a clinically useful tool, particularly for those with less
experience in the field.
Guidelines in themselves may not ensure change in supportive
behaviours.10 Therefore, our next steps are to use these standards to
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explore current practice in the UK through a clinical case note audit of
diagnosis of YOD using a digital platform. The goal is to identify com-
pliance with the quality indicators in mental health settings across the
UK to assess current clinical practice and to identify potential barriers
and facilitators to high quality assessment.
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APPENDIX: Round 1, patient vignette and open-ended questions
APPENDIX: Statements formulated for Round 2
Please read the vignette below:
Mr Smith, a 60-year old, right handed retired accountant is referred to your clinic by his GP (Primary care physician US). He attends alone. His wife is
concerned about his memory but she is at work and unable to attend. Mr Smith is a little dishevelled, and somewhat over familiar in manner. Mr Smith,
does not feel he has any particular problems, says his wife is always nagging him and he sometimes worries she may be having an affair. He agrees that he
sometimes forgets what he wants to say mid-sentence, has occasionally misplaced his keys and has lost interest in reading which he previously enjoyed. His
golf buddies joke with him that he has poor head for numbers and they help him keep track of the scores. He has no significant past medical history, takes
no regular medication and lives at home with his wife. His mother died in her 60s in a care home, with dementia. On further enquiry, Mr S reports that for
the past 6 months, he has been sleeping poorly and admits that he worries about his son who is going through a difficult divorce. He still drives and
manages the family accounts. Basic cognitive testing with the ACE-III demonstrates a total score of 77/100 with the following subset scores: Attention 16/
18, memory 19/26, verbal fluency 10/14, VS 10/16, language 22/26.
With regards to this vignette, and making a diagnosis, please answer the following questions:
Which are the key elements in the history that raise concern, if any? Could you outline them and explain why they are of note?
What further information would you require in order to refine your thinking?
What other tests might you undertake at this stage?
Please feel free to note any concerns or additional information you regard as important when diagnosing YOD:
Group and group statements Specific statements
Pre-assessment counselling Start with pre-assessment counselling to ascertain what patient and supporters require
Baseline Assessments - Please rate
how important you personally
deem the following baseline
assessments to be in making a
diagnosis of Young Onset Dementia
A basic/route dementia blood screen
A chest x-ray
An ECG
A Physical Examination
A screen for autoimmune disorders (eg, ANA, ANCA, paraneoplastic)
Please rate the importance of
obtaining the following information
when taking a clinical history in a
younger person with possible
cognitive impairment:
To ask an informant (eg, wife/husband) for a collateral history
To understand the symptom type and the mode of onset
More information about loss of sympathy/empathy towards others, disinhibited behaviour, change in food
preferences and changes in personality
To enquire if there are any swallowing difficulties
To enquire about changes in physical health
To ask about sleep
To have a full medical history (including cardiovascular history)
To understand the patients occupational history
To consider previous medical conditions
To assess for previous head injuries
To take a drug history
To take an alcohol history
To ask about stressful life events
If there have been any changes in activities of daily living
10 O'MALLEY ET AL.
Group and group statements Specific statements
To ask about changes in behaviour
To obtain for a three generation history of young onset dementia from the patient
To ask if a first degree relative has had young onset dementia
To evaluate risks, for example driving or in the work place
A thorough psychiatric history should
be conducted. Please rate this:
Exclude Symptoms of mood disorder
The psychiatric assessment should: Use a mood inventory such as GDS, BDI, HADS
Exclude psychotic symptoms
Use an inventory for neuropsychiatric symptoms such as NPI
Establish if there is a known history of learning disability
Ask about past psychiatric symptoms
A thorough neurological assessment
should be conducted. Please rate
this:
Praxis
Key components of the neurological
examination should include
assessment of:
Eye movements
Cerebellar signs
Extrapyramidal features
Motor Skills
Parkinsonism
Tongue or limb fasciculation
Frontal signs
A thorough psychiatric assessment
should be conducted. Please rate
this:
A mental state examination
Key components of the psychiatric
assessment should include:
Please rate the following statements: Ensuring the patient has capacity
Diagnosis of YOD is a clinical judgement and has a profound impact on the future, so it important to convey
this to patient and their family and remain open to the need to review and potentially modify opinion.
Establishing rapport to enable open reporting of symptoms
Neuroimaging investigation should
include:
Baseline structural neuroimaging
CT
MRI should be the initial imaging investigation
volumetric analysis of MRI
Assessment of MTL atrophy on MRI
MRI head to agreed dementia protocol
Dementia Protocol should include
each of the following:
3D T1
FLAIR
T2
SWI
DWI
In the event of normal baseline
imaging, it would be best to
consider:
CSF analysis for routine constituents
CSF analysis for biomarkers that is, TAU and AB42 markers
FDG-PET if available
HMPAO-SPECT if available
(Continues)
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APPENDIX: Statements where consensus was not reached and or
rated not important after all rounds
Group and group statements Specific statements
AMYLOID-PET if available
Genotyping
Please add any additional comments below to explain your reasoning
Cognitive Assessment. Please rate the
following statements:
An ACE-III is useful to understand the cognitive profile
Pre-morbid occupational functioning is a guide to expected performance on ACE-III
Assessment of sub-optimal performance on ACE-III depends on pre-morbid level of functioning
Patterns of cognitive deficits provide clues to disease aetiology on the ACE-III
Detailed neuropsychology testing is essential if there is under performance on screening measures
Detailed neuropsychology testing should be considered if under performance on screening measures
The profile of results is important on the ACE-III, that is, the pattern of what looks impaired and what is less
affected rather than the score itself
Functional Assessment (day to day
activities):
A functional assessment with an Occupational Therapist (OT) is useful.
Approach to management. Please rate
the following statements:
Multiple professionals are required over time to allow flexible assessment with disease progression
Support is required from diagnosis to end of life care
Statements Round 3 mean SD
Sum of experts rating
statements as very
important6 or absolutely
essential7
Sum of experts rating
statements as not at all
important1 or low
importance2
A basic/routine dementia blood screen 5.96 1.27 16 0
A chest x-ray 2.57 1.47 1 14
An ECG 2.96 1.43 1 8
A screen for autoimmune disorders (eg, ANA, ANCA,
paraneoplastic)
3.83 1.43 2 4
To enquire if there are any swallowing difficulties 5.87 0.99 16 0
To understand the patient's occupational history 5.91 0.78 17 0
To assess for previous head injuries 5.87 0.80 14 0
To ask about stressful life events 6.00 0.83 17 0
Use a mood inventory such as GDS, BDI, HADS 4.22 1.38 3 4
Use an inventory for neuropsychiatric symptoms such as NPI 4.13 1.57 4 4
CT 3.48 1.56 4 7
Volumetric analysis of MRI 4.87 1.54 8 2
SWI 5.87 0.90 16 0
DWI 5.83 0.96 16 0
CSF analysis for routine constituents 4.57 1.58 4 3
CSF analysis for biomarkers that is, TAU and AB42 markers 5.61 0.97 15 0
FDG-PET if available 5.30 1.04 9 0
HMPAO-SPECT if available 3.57 1.84 4 8
AMYLOID-PET if available 5.00 1.25 9 2
Genotyping 4.04 1.55 5 5
Pre-morbid occupational functioning is a guide to expected
performance on ACE-III
5.39 1.21 13 1
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Statements Round 3 mean SD
Sum of experts rating
statements as very
important6 or absolutely
essential7
Sum of experts rating
statements as not at all
important1 or low
importance2
Assessment of sub-optimal performance on ACE-III depends on
pre-morbid level of functioning
5.65 0.87 16 0
Detailed neuropsychology testing is essential if there is under
performance on screening measures
5.13 1.68 11 3
A functional assessment with an Occupational Therapist (OT) is
useful.
4.91 1.02 7 1
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